MapLight Therapeutics

MPLTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$551.857 M

$12.17 -8.36%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$161.2M

Loss-making

Shares outstanding

42,436,326

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#203Silence TherapeuticsSLN$559.3M
#204Shattuck LabsSTTK$557.5M
#205MapLight TherapeuticsMPLT$551.9M
#206BioAge LabsBIOA$537.9M
#207Relmada TherapeuticsRLMD$518.2M

Where these numbers come from

Share counts and financials for MapLight Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.